This phase 2 trial tests a new drug called ZN-c3 combined with the chemotherapy gemcitabine in 12 people with advanced pancreatic cancer that has worsened after platinum-based treatment. The goal is to see if the combination is safe and can slow cancer growth. Participants take Z…
Phase: PHASE2 • Sponsor: Brandon Huffman, MD • Aim: Disease control
Last updated Jun 23, 2026 12:08 UTC